The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future

JM Foster, C Zhang, S Rehman… - CA: A Cancer …, 2023 - Wiley Online Library
Peritoneal metastasis (PM) is often regarded as a less frequent pattern of spread; however,
collectively across all spectra of primary tumors, the consequences of PM impact a large …

Advances in the management of peritoneal malignancies

V Kepenekian, A Bhatt, J Peron, M Alyami… - Nature Reviews …, 2022 - nature.com
Peritoneal surface malignancies (PSMs) are usually associated with a poor prognosis.
Nonetheless, in line with advances in the management of most abdominopelvic metastatic …

Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up

S Kusamura, V Kepenekian, L Villeneuve… - European Journal of …, 2021 - Elsevier
Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis,
treatment and follow-up - ScienceDirect Skip to main contentSkip to article Elsevier logo …

[HTML][HTML] Malignant peritoneal mesothelioma: a review

G Broeckx, P Pauwels - Translational lung cancer research, 2018 - ncbi.nlm.nih.gov
Malignant peritoneal mesothelioma (MPM) is a very rare malignancy of the peritoneum and
has a poor prognosis. Of all mesotheliomas, pleural mesothelioma is more common than …

Effects of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy and neoadjuvant intraperitoneal/systemic chemotherapy on peritoneal metastases …

Y Yonemura, H Ishibashi, M Hirano, A Mizumoto… - Annals of surgical …, 2017 - Springer
Abstract Background The Peritoneal Cancer Index (PCI) is the most important prognostic
factor following comprehensive treatment for peritoneal metastasis (PM) from gastric cancer …

Malignant peritoneal mesothelioma: an in-depth and up-to-date review of pathogenesis, diagnosis, management and future directions

JB Karpes, R Shamavonian, S Dewhurst, E Cheng… - Cancers, 2023 - mdpi.com
Simple Summary Mesothelioma is a malignancy of mesothelial tissues. The majority arise
from the pleura, but approximately thirty percent of cases arise from the peritoneum …

Diagnostic and therapeutic pathway in diffuse malignant peritoneal mesothelioma

S Kusamura, D Baratti, M De Simone, EM Pasqual… - Cancers, 2023 - mdpi.com
Simple Summary Mesothelioma is a rare cancer that originates in mesothelial surfaces of
the peritoneum, pleura, and other sites. Diffuse malignant peritoneal mesothelioma (DMPM) …

Impact of Perioperative Systemic Chemotherapy on Survival for Patients Who have Diffuse Malignant Peritoneal Mesothelioma Treated with CRS–HIPEC

A Chatterjee, S Kusamura, D Baratti, M Guaglio… - Annals of Surgical …, 2024 - Springer
Background The available data on the role of perioperative systemic chemotherapy (SC) for
diffuse malignant peritoneal mesothelioma (DMPM) patients undergoing (CRS) and …

Treatment of patients with malignant peritoneal mesothelioma

CY Li, T Kennedy, HR Alexander - Journal of Clinical Medicine, 2022 - mdpi.com
Malignant peritoneal mesothelioma is a rare malignancy arising from the serosa of the
peritoneal cavity. It is diagnosed based on suspicious findings on cross sectional imaging …

Drug sensitivity tumor cell clusters in malignant peritoneal mesothelioma

YD Su, R Ma, YB Fu, HL Wu, XL Liang… - Journal of Surgical …, 2024 - Wiley Online Library
Background To explore the most effective adjuvant chemotherapy regimen for malignant
peritoneal mesothelioma (MPM) through patient derived tumor‐like cell clusters (PTC) drug …